Onyx Biotec Ipo

Upgradation of existing manufacturing Unit I to manufacture large volume parentals for intravenous use;

Setting up a high-speed cartooning packaging line at existing manufacturing Unit II for Dry Powder Injections;

Prepayment or repayment of all or a portion of certain loans availed by the Company; and

General Corporate Purposes.

IPO Watch – May Apply

Canara Bank –

DRChoksey FinServ –

Emkay Global –

Hem Securities –

IDBI Capital –

Marwadi Shares –

Nirmal Bang –

SBICAP Securities –

Sharekhan –

SMC Global –

Sushil Finance –

Swastika Investmart –

Ventura Securities –

Geojit –

Reliance Securities –

Capital Market –

BP Wealth –

ICICIdirect –

Choice Broking –

Horizon Management Private Limited